Wang L, Chen Y, Zang M, Zhou J, et al. Molecular measurable residual disease before transplantation independently predicts survival and relapse risk in adult lysine methyltransferase 2a-rearranged acute myeloid leukemia. Cancer 2025;131:e35717.
PMID: 39760486